NSAID-induced reactions: classification, prevalence, impact, and management strategies

References

• Doña I, Blanca-López N, Torres MJ, et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol. 2012;22(5):363–371.
   PubMed Web of Science ®Google Scholar
• Blanca-López N, Pérez-Alzate D, Canto G, Blanca M. Practical approach to the treatment of NSAID hypersensitivity. Expert Rev Clin Immunol. 2017;13(11):1017–1027.28893093
   PubMed Web of Science ®Google Scholar
• Doña I, Blanca-López N, Cornejo-García JA, et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy. 2011;41(1):86–95.21155908
   PubMed Web of Science ®Google Scholar
• Messaad D, Sahla H, Benahmed S, et al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med. 2004;140(12):1001–1006.15197017
   PubMed Web of Science ®Google Scholar
• Jares EJ, Baena-Cagnani CE, Sánchez-Borges M, et al. Drug-induced anaphylaxis in Latin American countries. J Allergy Clin Immunol Pract. 2015;3(5):780–788.26143020
   PubMed Web of Science ®Google Scholar
• Çelik G, Pichler WJ, Adkinson NF. Drug allergy. In: Adkinson NF, Brocher BS, Busse WW, Holgate ST, Lemanske RF, Simons FER. Middleton’s Allergy Principles & Practise. Vol 2 7th ed. St. Louis, MO: Mosby Elsevier; 2009; Chapter 68: 1205–1226.
   Google Scholar
• Zhou L, Dhopeshwarkar N, Blumenthal KG, et al. Drug allergies documented in electronic health records of a large healthcare system. Allergy. 2016;71(9):1305–1313.26970431
   PubMed Web of Science ®Google Scholar
• Xing Y, Zhang H, Sun S, et al. Clinical features and treatment of pediatric patients with drug-induced anaphylaxis: a study based on pharmacovigilance data. Eur J Pediatr. 2018;177(1):145–154.29168013
   PubMed Web of Science ®Google Scholar
• Blanca M. Allergic reactions to amoxicillin. A changing world? Allergy. 1995;50:772–782.
   Web of Science ®Google Scholar
• Blanca M, Mayorga C, Torres MJ, et al. Side-chain-specific reactions to betalactams: 14 years later. Clin Exp Allergy. 2002;32(2):192–197.11929481
   PubMed Web of Science ®Google Scholar
• Brunton LL, Hilal-Dandan R, Knollmann BC. Goodman and Gilman´s: The Pharmacological Basis of Therapeutics. 13th ed. New York: McGrawHill; 2017.
   Google Scholar
• Szczeklik A, Nizankowska-Mogilnicka E, Sanak M. Hypersensitivity to aspirin and non-steroidal antiinflammatory drugs. In: Adkinson NF, Brocher BS, Busse WW, Holgate ST, Lemanske RF, Simons FER, editors. Middleton´s Allergy Principles & Practise. Vol 2 7th ed. St. Louis, MO: Mosby Elsevier; 2009; Chapter 69: 1227–1243.
   Google Scholar
• Network for the Study of Adverse Reactions to Drug and Allergens (RIRAAF). ISCiii, Madrid, Spain. Available from: https://chirimoyo.ac.uma.es/riraaf/. Accessed February 2, 2019.
   Google Scholar
• Blanca-López N, Barrionuevo E, Andreu I, Canto MG. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: from phenotyping to genotyping. Curr Opin Allergy Clin Immunol. 2014;14(4):271–277.24915547
   PubMed Web of Science ®Google Scholar
• Ayuso P, Cornejo-García JA, Blanca-López N, Doña I. Advanced phenotyping in hypersensitivity drug reactions to NSAIDs. Clin Exp Allergy. 2013;43(10):1097–1109.24074328
   PubMed Web of Science ®Google Scholar
• Gómez F, Perkins JR, García-Martín E, Canto G, Cornejo-García JA. Genetic basis of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Curr Opin Allergy Clin Immunol. 2015;15(4):285–293.26110677
   PubMed Web of Science ®Google Scholar
• Plaza-Serón MDC, García-Martín E, Agúndez JA, Ayuso P. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: an update on pharmacogenetics studies. Pharmacogenomics. 2018;19(13):1069–1086.30081739
   PubMed Web of Science ®Google Scholar
• Perkins JR, Barrionuevo E, Ranea JA, Blanca M, Cornejo-Garcia JA. Systems biology approaches to enhance our understanding of drug hypersensitivity reactions. Clin Exp Allergy. 2014;44(12):1461–1472.25040150
   PubMed Web of Science ®Google Scholar
• Pham DL, Jim JH, Park HS. What we know about non-steroidal drug hypersensitivity. Korean J Intern Med. 2016;3:417–432.
   Web of Science ®Google Scholar
• Kim SH, Sanak M, Park HS. Genetics of hypersensitivity to aspirin and nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am. 2013;33(2):177–194.23639707
   PubMed Web of Science ®Google Scholar
• Kidon M, Blanca-Lopez N, Gomes E, et al. EAACI/ENDA position paper: diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents. Pediatr Allergy Immunol. 2018;29(5):469–480.29693290
   PubMed Web of Science ®Google Scholar
• Blanca-López N, Pérez-Alzate D, Somoza ML, et al. Pattern of responses of hypersensitivity reactions to NSAIDs in adolescents and young adults. Allergy. 2018;73(S105):1757.
   Google Scholar
• Guéant JL, Romano A, Cornejo-Garcia JA, et al. HLA-DRA variants predict penicillin allergy in genome-wide fine-mapping genotyping. J Allergy Clin Immunol. 2015;135(1):253–259.25224099
   PubMed Web of Science ®Google Scholar
• Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol. 2015;135(3):676–681.25282015
   PubMed Web of Science ®Google Scholar
• Bavbek S, Yılmaz İ, Çelik G, et al. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey. Allergol Immunopathol. 2012;40(4):225–230.
   PubMed Web of Science ®Google Scholar
• Hayashi H, Mitsui C, Nakatani E, et al. Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(5):1585–1587.26559322
   PubMed Web of Science ®Google Scholar
• Blanca-López N, Torres JM, Doña I, et al. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance. Clin Exp Allergy. 2013;43(1):85–91.23278883
   PubMed Web of Science ®Google Scholar
• Asero R. Single NSAID hypersensitivity is associated with atopic status. Eur Ann Allergy Clin Immunol. 2015;47(2):48–53.25781194
   PubMedGoogle Scholar
• Blanca-López N, Pérez-Alzate D, Andreu I, et al. Immediate hypersensitivity reactions to ibuprofen and other arylpropionic acid derivatives. Allergy. 2016;71(7):1048–1056.26841325
   PubMed Web of Science ®Google Scholar
• Blanca-López N, Bogas G, Doña I, et al. ASA must be given to classify multiple NSAID-hypersensitivity patients as selective or cross-intolerant. Allergy. 2016;71(4):576–578.27003105
   PubMed Web of Science ®Google Scholar
• Pérez-Alzate D, Cornejo-García JA, Pérez-Sánchez N, et al. Immediate reactions to more than 1 NSAID must not be considered cross-hypersensitivity unless tolerance to ASA is verified. J Investig Allergol Clin Immunol. 2017;27(1):32–39.
   PubMed Web of Science ®Google Scholar
• Pérez-Alzate D, Blanca-López N, Doña I, et al. Asthma and rhinitis induced by selective immediate reactions to paracetamol and non-steroidal anti-inflammatory drugs in aspirin tolerant subjects. Front Pharmacol. 2016;7:215.27489545
   PubMed Web of Science ®Google Scholar
• Blanca-López N, Doña I, Perkins JR, et al. Multiple nonsteroidal anti-inflammatory drug-induced cutaneous disease: relevance, natural evolution and relationship with atopy. Int Arch Allergy Immunol. 2014;164(2):147–148.25012690
   PubMed Web of Science ®Google Scholar
• Tuttle KL, Schneider TR, Henrickson SE, et al. Aspirin-exacerbated respiratory disease: not always “adult-onset”. J Allergy Clin Immunol Pract. 2016;4(4):756–758.27393784
   PubMed Web of Science ®Google Scholar
• Ertoy Karagol HI, Yilmaz O, Topal E, Ceylan A, Bakirtas A. Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents. Int Forum Allergy Rhinol. 2015;5(5):392–398.25755210
   PubMed Web of Science ®Google Scholar
• Cavkaytar O, Arik Yilmaz E, Karaatmaca B, et al. Different phenotypes of non-steroidal anti-inflammatory drug hypersensitivity during childhood. Int Arch Allergy Immunol. 2015;167(3):211–221.26315297
   PubMed Web of Science ®Google Scholar
• Yilmaz O, Ertoy Karagol IH, Bakirtas A, et al. Challenge-proven nonsteroidal anti-inflammatory drug hypersensitivity in children. Allergy. 2013;68(12):1555–1561.24117618
   PubMed Web of Science ®Google Scholar
• Blanca M, Garcia J, Vega JM, et al. Anaphylaxis to penicillins after non-therapeutic exposure: an immunological investigation. Clin Exp Allergy. 1996;26(3):335–340.8729672
   PubMed Web of Science ®Google Scholar
• Demir S, Olgac M, Unal D, et al. Evaluation of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs according to the latest classification. Allergy. 2015;70(11):1461–1467.26173603
   PubMed Web of Science ®Google Scholar
• Caimmi S, Caimmi D, Bousquet PJ, Demoly P. How can we better classify NSAID hypersensitivity reactions?–validation from a large database. Int Arch Allergy Immunol. 2012;159(3):306–312.22739440
   PubMed Web of Science ®Google Scholar
• Kidon MI, Liew WK, Chiang WC, et al. Hypersensitivity to paracetamol in Asian children with early onset of nonsteroidal anti-inflammatory drug allergy. Int Arch Allergy Immunol. 2007;144(1):51–56.17505137
   PubMed Web of Science ®Google Scholar
• Cornejo-García JA, Liou LB, Blanca-López N, et al. Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populations. Pharmacogenomics. 2013;14(15):1857–1869.24236485
   PubMed Web of Science ®Google Scholar
• Alves C, Romeira AM, Abreu C, et al. Non-steroidal anti-inflammatory drug hypersensitivity in children. Allergol Immunopathol. 2017;45(1):40–47.
   PubMed Web of Science ®Google Scholar
• Hassani A, Ponvert C, Karila C, et al. Hypersensitivity to cyclooxygenase inhibitory drugs in children: a study of 164 cases. Eur J Dermatol. 2008;18(5):561–565.18693161
   PubMed Web of Science ®Google Scholar
• Kidon MI, Kang LW, Chin CW, et al. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children. Pediatrics. 2005;116(5): e675–e680.
   Web of Science ®Google Scholar
• Cavkaytar O, Arik Yilmaz E, Buyuktiryaki B, et al. Challenge-proven aspirin hypersensitivity in children with chronic spontaneous urticaria. Allergy. 2015;70(2):153–160.25353369
   PubMed Web of Science ®Google Scholar
• Calvo Campoverde K, Giner-Muñoz MT, Martínez Valdez L, et al. Hypersensitivity reactions to non-steroidal anti-inflammatory drugs and tolerance to alternative drugs. An Pediatr (Barc). 2016;84:148–153.26195066
   PubMed Web of Science ®Google Scholar
• Ameratunga R, Randall N, Dalziel S, Anderson BJ. Samter’s triad in childhood: a warning for those prescribing NSAIDs. Paediatr Anaesth. 2013;23(8):757–759.23782034
   PubMed Web of Science ®Google Scholar
• Blanca-López N, Cornejo-García JA, Pérez-Alzate D, et al. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs in children and adolescents: selective reactions. J Investig Allergol Clin Immunol. 2015;25(6):385–395.
   PubMed Web of Science ®Google Scholar
• Blanca-López N, Cornejo-García JA, Plaza-Serón MC, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs in children and adolescents: cross-intolerance reactions. J Investig Allergol Clin Immunol. 2015;25(4):259–269.
   PubMed Web of Science ®Google Scholar
• Lovell DJ, Dare JA, Francis-Sedlak M, et al. A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2018;16(1):41.29941047
   PubMed Web of Science ®Google Scholar
• Predel HG, Giannetti B, Connolly MP, Lewis F, Bhatt A. Efficacy and tolerability of a new ibuprofen 200 mg plaster in patients with acute sports-related traumatic blunt soft tissue injury/contusion. Postgrad Med. 2018;130(1):24–31.29110567
   PubMed Web of Science ®Google Scholar
• Predel HG, Connolly MP, Bhatt A, et al. Efficacy and safety assessment of acute sports-related traumatic soft tissue injuries using a new ibuprofen medicated plaster: results from a randomized controlled clinical trial. Phys Sportsmed. 2017;45(4):418–425.28926295
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Makowska JS, Blanca M, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy. 2011;66(7):818–829.21631520
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68(10):1219–1232.24117484
   PubMed Web of Science ®Google Scholar
• Blanca-López N, Somoza-Alvarez ML, Bellon T, et al. NSAIDs hypersensitivity: questions not resolved. Curr Opin Allergy Clin Immunol. 2018;18(4):291–301.29878898
   PubMed Web of Science ®Google Scholar
• Cahill KN, Boyce JA. Aspirin-exacerbated respiratory disease: mediators and mechanisms of a clinical disease. J Allergy Clin Immunol. 2017;139(3):764–766.27771324
   PubMed Web of Science ®Google Scholar
• Buchheit KM, Cahill KN, Katz HR, et al. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(5):1566–1576.26691435
   PubMed Web of Science ®Google Scholar
• Pérez-Novo CA, Watelet JB, Claeys C, van Cauwenberge P, Bachert C. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol. 2005;115(6):1189–1196.15940133
   PubMed Web of Science ®Google Scholar
• Steinke JW, Negri J, Liu L, Payne SC, Borish L. Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease. J Immunol. 2014;193(1):41–47.24890720
   PubMed Web of Science ®Google Scholar
• Fajmut A, Emeršič T, Dobovišek A, et al. Dynamic model of eicosanoid production with special reference to non-steroidal anti-inflammatory drug-triggered hypersensitivity. IET Syst Biol. 2015;9(5):204–215.26405144
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Agache I, Bavbek S, et al. Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)-a EAACI position paper. Allergy. 2019;74(1):28–39.30216468
   PubMed Web of Science ®Google Scholar
• Liu T, Laidlaw TM, Katz HR, Boyce JA. Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes. Proc Natl Acad Sci U S A. 2013;110(42):16987–16992.24085850
   PubMed Web of Science ®Google Scholar
• Aktas A, Kurt E, Gulbas Z. Cytokine expression before and after aspirin desensitization therapy in aspirin-exacerbated respiratory disease. Inflammation. 2013;36(6):1553–1559.23912646
   PubMed Web of Science ®Google Scholar
• Samter M, Beers RF Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68(5):975–983.5646829
   PubMed Web of Science ®Google Scholar
• Bavbek S, Celik G, Demirel YS, Misirligil Z. Risk factors associated with hospitalizations for asthma attacks in turkey. Allergy Asthma Proc. 2003;24(6):437–442.14763246
   PubMed Web of Science ®Google Scholar
• Makowska JS, Burney P, Jarvis D, et al. Respiratory hypersensitivity reactions to NSAIDs in Europe: the global allergy and asthma network (GA(2)LEN) survey. Allergy. 2016;71:1603–1611.27230252
   PubMed Web of Science ®Google Scholar
• Morales DR, Guthrie B, Lipworth BJ, et al. NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity. Allergy. 2015;70(7):828–835.25855099
   PubMed Web of Science ®Google Scholar
• Cavkaytar O, Arik Yilmaz E, Karaatmaca B, et al. Different phenotypes of non-steroidal anti-inflammatory drug hypersensitivity during childhood. Int Arch Allergy Immunol. 2015;167(3):211–221.26315297
   PubMed Web of Science ®Google Scholar
• Pérez-Alzate D, Blanca-López N, Doña I, et al. Asthma and rhinitis induced by selective immediate reactions to paracetamol and non-steroidal anti-inflammatory drugs in aspirin tolerant subjects. Front Pharmacol. 2016;7:215.27489545
   PubMed Web of Science ®Google Scholar
• Palikhe S, Palikhe NS, Kim SH, et al. Elevated platelet activation in patients with chronic urticaria: a comparison between aspirin-intolerant and aspirin-tolerant groups. Ann Allergy Asthma Immunol. 2014;113(3):276–281.25037610
   PubMed Web of Science ®Google Scholar
• Aun MV, Blanca M, Garro LS, et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014;2(4):414–420.25017529
   PubMed Web of Science ®Google Scholar
• Mastalerz L, Setkowicz M, Sanak M, Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol. 2004;113(4):771–775.15100686
   PubMed Web of Science ®Google Scholar
• Lee HY, Ye YM, Kim SH, et al. Identification of phenotypic clusters of nonsteroidal anti-inflammatory drugs exacerbated respiratory disease. Allergy. 2017;72(4):616–626.27805264
   PubMed Web of Science ®Google Scholar
• Campo P, Ayuso P, Salas M, et al. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs. Allergy. 2013;68(8):1001–1007.23889565
   PubMed Web of Science ®Google Scholar
• Zambonino MA, Torres MJ, Muñoz C, et al. Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children. Pediatr Allergy Immunol. 2013;24(2):151–159.23506290
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Stevenson DD. Classification of reactions to nonsteroidal antiinflammatory drugs. Immunol Allergy Clin North Am. 2013;33(2):135–145.23639704
   PubMed Web of Science ®Google Scholar
• Ortega Rodriguez NR, Doña Díaz I, Blanca-López N, et al. Hipersensibilidad a los antiinflamatorios no esteroideos. In: Dávila González IJ, Jáuregui Presa I, Olaguibel Rivera JM, Zubeldia Ortuño JM, editors. Tratado de Alergología. 2nd edition. Madrid: Ergon; 2016; Vol 4, Chapter 19: 1551–1570.
   Google Scholar
• Giner MT. Alergia a Fármacos. In: Martín Mateos MA, editor. Tratado de Alergología Pediátrica. 2nd ed. Madrid: Ergon; 2011 Chapter 20: 247–263.
   Google Scholar
• Blanca-López N, Pérez-Alzate D, Canto G, Blanca M. Practical approach to the treatment of NSAID hypersensitivity. Expert Rev Clin Immunol. 2017;13(11):1017–1027.28893093
   PubMed Web of Science ®Google Scholar
• Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on aspirin-induced asthma. Eur Respir J. 2000;16(3):432–436.11028656
   PubMed Web of Science ®Google Scholar
• Carmona MJ, Blanca M, Garcia A, et al. Intolerance to piroxicam in patients with adverse reactions to nonsteroidal antiinflammatory drugs. J Allergy Clin Immunol. 1992; 90(6 Pt 1):873–879.1460195
   PubMed Web of Science ®Google Scholar
• Setkowicz M, Mastalerz L, Podolec-Rubis M, et al. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years. J Allergy Clin Immunol. 2009;123:174–178.18842291
   PubMed Web of Science ®Google Scholar
• Capone ML, Tacconelli S, Di Francesco L, Sacchetti A, Sciulli MG, Patrignani P. Pharmacodynamic of cyclooxygenase inhibitors in humans. Prostaglandins Other Lipid Mediat. 2007;82(1–4):85–94.17164136
   PubMed Web of Science ®Google Scholar
• Pérez-Sánchez N, Bogas G, Cornejo-García JA, et al. Multiple nonsteroidal anti-inflammatory drug hypersensitivity without hypersensitivity to aspirin. J Allergy Clin Immunol Pract. 2016;4(3):524–525.26781480
   PubMed Web of Science ®Google Scholar
• Macías E, Ruiz A, Moreno E, et al. Usefulness of intradermal test and patch test in the diagnosis of nonimmediate reactions to metamizol. Allergy. 2007;62(12):1462–1464.17983381
   PubMed Web of Science ®Google Scholar
• Loh TY, Cohen PR. Ketoprofen-induced photoallergic dermatitis. Indian J Med Res. 2016;144(6):803–806.28474616
   PubMed Web of Science ®Google Scholar
• Monteiro AF, Rato M, Martins C. Drug-induced photosensitivity: photoallergic and phototoxic reactions. Clin Dermatol. 2016;34(5):571–581.27638435
   PubMed Web of Science ®Google Scholar
• Canto MG, Andreu I, Fernandez J, Blanca M. Selective immediate hypersensitivity reactions to NSAIDs. Curr Opin Allergy Clin Immunol. 2009;9(4):293–297.19561490
   PubMed Web of Science ®Google Scholar
• Borja JM, Galindo PA, Gomez E, Feo F. Delayed skin reactions to metamizol. Allergy. 2003;58(1):84–85.12580814
   PubMed Web of Science ®Google Scholar
• Angadi SS, Karn A. Ibuprofen induced Stevens-Johnson syndrome – toxic epidermal necrolysis in Nepal. Asia Pac Allergy. 2016;6(1):70–73.26844223
   PubMedGoogle Scholar
• Gulin SJ, Chiriac A. Diclofenac-Induced allergic contact dermatitis: a series of four patients. Drug Saf Case Rep. 2016;3(1):15.27882527
   PubMedGoogle Scholar
• Gómez E, Blanca-López N, Torres MJ, et al. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy. 2009;39(8):1217–1224.19400910
   PubMed Web of Science ®Google Scholar
• Himly M, Jahn-Schmid B, Pittertschatscher K, et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol. 2003;111(4):882–888.12704373
   PubMed Web of Science ®Google Scholar
• Ariza A, García-Martín E, Salas M, et al. Pyrazolones metabolites are relevant for identifying selective anaphylaxis to metamizole. Sci Rep. 2016;6:23845.27030298
   PubMed Web of Science ®Google Scholar
• Blanca M, Perez E, Garcia JJ, et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy. 1989;62(4):295–298.2468301
   PubMedGoogle Scholar
• Harrer A, Lang R, Grims R, et al. Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites. PLoS One. 2010;5(10):e13707.21060839
   PubMed Web of Science ®Google Scholar
• Levy M, Zylber-Katz E, Rosenkranz B. Clinical pharmacokinetics of dipyrone and its metabolites. Clin Pharmacokinet. 1995;28(3):216–234.7758252
   PubMed Web of Science ®Google Scholar
• Herdeg C, Hilt F, Büchtemann A, Bianchi L, Klein R. Allergic cholestatic hepatitis and exanthema induced by metamizole: verification by lymphocyte transformation test. Liver. 2002;22(6):507–513.12445177
   PubMedGoogle Scholar
• Federmann G, Becker EW, Tautorat H, Penschuck C, Berg PA. [Demonstration by lymphocyte transformation test of the allergic genesis in a case of acute hepatitis]. Dtsch Med Wochenschr. 1988;113(43):1676–1679. German.2903041
   PubMed Web of Science ®Google Scholar
• Mockenhaupt M. Epidemiology of cutaneous adverse drug reactions. Chem Immunol Allergy. 2012;97:1–17.22613850
   PubMedGoogle Scholar
• Drucker AM, Rosen CF. Drug-induced photosensitivity: culprit drugs, management and prevention. Drug Saf. 2011;34(10):821–837.21879777
   PubMed Web of Science ®Google Scholar
• Marchand MS, Autret-Leca E, Bourdais E, Jonville-Béra AP. [Photoallergy to piroxicam: what should be contraindicates?]. Therapie. 2013;68(1):57–58. French.23484664
   PubMed Web of Science ®Google Scholar
• Chen CB, Abe R, Pan RY, et al. An updated review of the molecular mechanisms in drug hypersensitivity. J Immunol Res. 2018;2018(3):1–22.
   Google Scholar
• Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018;54(1):147–176.29188475
   PubMed Web of Science ®Google Scholar
• Balta I, Simsek H, Simsek GG. Flurbiprofen-induced generalized bullous fixed drug eruption. Hum Exp Toxicol. 2014;33(1):106–108.23703815
   PubMed Web of Science ®Google Scholar
• Rho YK, Yoo KH, Kim BJ, Kim MN, Song KY. A case of generalized fixed drug eruption due to a piroxicam plaster. Clin Exp Dermatol. 2010;35(2):204–205.20447085
   PubMed Web of Science ®Google Scholar
• Arochena L, Zafra MP, Fariña MC, del Pozo V, Fernández-Nieto M. Acute generalized exanthematic pustulosis due to ibuprofen. Ann Allergy Asthma Immunol. 2013;110(5):386–387.23622012
   PubMed Web of Science ®Google Scholar
• di Meo N, Stinco G, Patrone P, Trevisini S, Trevisan G. Acute localized exanthematous pustulosis caused by flurbiprofen. Cutis. 2016;98(5):E9–E11.28040819
   PubMed Web of Science ®Google Scholar
• Gómez E, Blanca-Lopez N, Salas M, et al. Induction of accelerated reactions to amoxicillin by T-cell effector mechanisms. Ann Allergy Asthma Immunol. 2013;110(4):267–273.23535091
   PubMed Web of Science ®Google Scholar
• Parra FM, Pérez Elias MJ, Cuevas M, Ferreira A. Serum sickness-like illness associated with rifampicin. Ann Allergy. 1994;73(2):123–125.8067595
   PubMedGoogle Scholar
• Kraleti S, Khatri N, Jarrett D. Serum sickness-like reaction after the treatment of cellulitis with amoxicillin/clavulanate. J Ark Med Soc. 2016;112:278–280.27434982
   PubMedGoogle Scholar
• Watanabe T, Abe M, Tada F, et al. Drug-induced liver injury with serious multiform exudative erythema following the use of an over-the-counter medication containing ibuprofen. Intern Med. 2015;54(4):395–399.25748955
   PubMed Web of Science ®Google Scholar
• Schmutz JL, Barbauda A, Trechot P. [Phenylbutazone and dress syndrome]. Ann Dermatol Venereol. 2010;137:857.21134594
   PubMed Web of Science ®Google Scholar
• Karmacharya P, Mainali NR, Aryal MR, et al. Recurrent case of ibuprofen-induced aseptic meningitis in mixed connective tissue disease. Case Rep. 2013; 2013: bcr2013009571.
   Google Scholar
• Baxter KA, Pucher PH, Berry DP, et al. The effect of non-steroidal anti-inflammatory drugs on severity of acute pancreatitis and pancreatic necrosis. Ann R Coll Surg Engl. 2018;100(3):199–202.29181999
   PubMed Web of Science ®Google Scholar
• Aynioglu A, Elicora A, Kaya S. Nicolau syndrome due to diclofenac injection. G Ital Dermatol Venereol. 2016;151(4):452–453.27348328
   PubMed Web of Science ®Google Scholar
• Arikoglu T, Aslan G, Yildirim DD, et al. Discrepancies in the diagnosis and classification of non-sdteroidal anti-inflammatory drugs hypersensitivity reactions in chlidren. Alergolo Int. 2017;66:418–24.
   PubMed Web of Science ®Google Scholar
• Avorn J. The role of Pharmacoepidemiology in the Health-Care System and Academia. In: Strom BL, Kimmel SE, Hennessy S, editors. Pharmacoepidemiology 5th ed. Hoboken, NJ: Wiley-Blackwell; 2012; Chapter 6: 73–83.
   Google Scholar
• Oosterhuis I, Zweers P, Rümke H, Muller-Hansma A, van Puijenbroek EP. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines. Pharmacoepidemiol Drug Saf. 2018;17(6).
   Google Scholar
• Nguyen KD, Tran TN, Nguyen MT, et al. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Vietnamese spontaneous adverse drug reaction database: a subgroup approach to disproportionality analysis. J Clin Pharm Ther. 2019;44(1):69–77.30129156
   PubMed Web of Science ®Google Scholar
• Kesselheim A. pharmacoepidemiology and the law In: Strom BL, Kimmel SE, Hennessy S, editors. Pharmacoepidemiology. 5th ed. Hoboken: Wiley-Blackwell; 2012; Chapter 9: 117–134.
   Google Scholar
• Cortellini G, Romano A, Santucci A, et al. Clinical approach on challenge and desensitization procedures with aspirin in patients with ischemic heart disease and nonsteroidal anti-inflammatory drug hypersensitivity. Allergy. 2017;72(3):498–506.27732743
   PubMed Web of Science ®Google Scholar
• Al-Ahmad M, Rodriguez-Bouza T, Nurkic M. Establishing a safe administration of ASA in cardiovascular patients with nonsteroidal anti-inflammatory drug hypersensitivity with skin and/or respiratory involvement. Int Arch Allergy Immunol. 2018;175(4):237–245.29393216
   PubMed Web of Science ®Google Scholar
• Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ. 2004;328(7437):434.14976098
   PubMed Web of Science ®Google Scholar
• Cardet JC, White AA, Barrett NA, et al. Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2014;2(2):208–213.24607050
   PubMed Web of Science ®Google Scholar
• Cornejo-Garcia J, Oussalah A, Blanca M, et al. Genetic predictors of drug hypersensitivity. Curr Pharm Des. 2017;22(45):6725–6733.
   Web of Science ®Google Scholar
• Cherrez-Ojeda I, Robles-Velasco K, Bedoya-Riofrío P, et al. Checklist for a complete chronic urticaria medical history: an easy tool. World Allergy Organ J. 2017;10(1):34.29043012
   PubMed Web of Science ®Google Scholar
• Doeglas HM. Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol. 1975;93(2):135–144.1100092
   PubMed Web of Science ®Google Scholar
• Doña I, Blanca-López N, Torres MJ, et al. NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study. Allergy. 2014;69(4):438–444.24372026
   PubMed Web of Science ®Google Scholar
• Goeschke B, Braathen LR. Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far. Dermatology. 2004;209(1):53–56.15237269
   PubMed Web of Science ®Google Scholar
• Hanafusa T, Azukizawa H, Matsumura S, et al. Non-pigmenting fixed drug eruption caused by an over-the-counter non-steroidal anti-inflammatory drug: drug-specific CD8+ T lymphocytes identified in peripheral blood. Eur J Dermatol. 2012;22(5):680–682.22854000
   PubMed Web of Science ®Google Scholar
• Roujeau J-C, Albengres E, Moritz S, et al. Lymphocyte transformation test in drug-induced toxic epidermal necrolysis. Int Arch Allergy Immunol. 1985;78(1):22–24.
   Web of Science ®Google Scholar
• Stevens WW, Schleimer RP. Aspirin-exacerbated respiratory disease as an endotype of chronic rhinosinusitis. Immunol Allergy Clin North Am. 2016;36(4):669–680.27712762
   PubMed Web of Science ®Google Scholar
• Lee HY, Ye YM, Kim SH, et al. Identification of phenotypic clusters of nonsteroidal anti-inflammatory drugs exacerbated respiratory disease. Allergy. 2017;72(4):616–626.27805264
   PubMed Web of Science ®Google Scholar
• Pali-Schöll I, Untersmayr E, Klems M, Jensen-Jarolim E, et al. The effect of digestion and digestibility on allergenicity of food. Nutrients. 2018;10(9):1129.
   Web of Science ®Google Scholar
• Fisher HR, du Toit G, Bahnson HT, et al. The challenges of preventing food allergy: lessons learned from leap and eat. Ann Allergy Asthma Immunol. 2018;121:313–319.29909054
   PubMed Web of Science ®Google Scholar
• Blanca-López N, Haroun-Diaz E, Ruano FJ, et al. Acetyl salicylic acid challenge in children with hypersensitivity reactions to nonsteroidal anti-inflammatory drugs differentiates between cross-intolerant and selective responders. J Allergy Clin Immunol Pract. 2018;6(4):1226–1235.28986120
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhin. 2012;50(1):1–12.
   Google Scholar
• Bavbek S, Yılmaz İ, Çelik G, et al. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey. Allergol Immunopathol. 2012;40(4):225–230.
   PubMed Web of Science ®Google Scholar
• Posadas SJ, Leyva L, Torres MJ, et al. Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J Allergy Clin Immunol. 2000;106(4):769–776.11031349
   PubMed Web of Science ®Google Scholar
• Blanca M, Posadas S, Torres MJ, et al. Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with nonimmediate cutaneous allergic drug reactions. Allergy. 2000;55(11):998–1004.11097307
   PubMed Web of Science ®Google Scholar
• Bellón T, Alvarez L, Mayorga C, et al. Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases. Br J Dermatol. 2010;162(5):1014–1022.20030638
   PubMed Web of Science ®Google Scholar
• Romano A, Blanca M, Torres MJ, et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy. 2004;59(11):1153–1160.15461594
   PubMed Web of Science ®Google Scholar
• Dalmau J, Serra-Baldrich E, Roé E, Peramiquel L, Alomar A. Use of patch test in fixed drug eruption due to metamizole (Nolotil). Contact Derm. 2006;54(2):127–128.
   Web of Science ®Google Scholar
• Macías E, Ruiz A, Moreno E, et al. Usefulness of intradermal test and patch test in the diagnosis of nonimmediate reactions to metamizol. Allergy. 2007;62(12):1462–1464.17983381
   PubMed Web of Science ®Google Scholar
• Romano A, Pietrantonio F, Di Fonso M, et al. Positivity of patch tests in cutaneous reaction to diclofenac. Two case reports. Allergy. 1994;49(1):57–59.8198241
   PubMed Web of Science ®Google Scholar
• Marques LP, Villarinho ALCF, Melo MDGM, Torre MGS. Fixed drug eruption to nimesulide: an exuberant presentation confirmed by patch testing. An Bras Dermatol. 2018;93(3):470–472.29924254
   PubMed Web of Science ®Google Scholar
• Kerr A, Ferguson J. Photoallergic contact dermatitis. Photodermatol Photoimmunol Photomed. 2010;26(2):56–65.20415735
   PubMed Web of Science ®Google Scholar
• Brockow K, Aberer W, Atanaskovic-Markovic M, et al. Drug allergy passport and other documentation for patients with drug hypersensitivity – an ENDA/EAACI Drug Allergy Interest Group Position Paper. Allergy. 2016;71(11):1533–1539.27145347
   PubMed Web of Science ®Google Scholar
• Doña I, Blanca-López N, Jagemann LR, et al. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs. Allergy. 2011;66(11):1428–1433.21834936
   PubMed Web of Science ®Google Scholar
• Torres MJ, Barrionuevo E, Kowalski M, Blanca M. Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am. 2014;34(3):507–524.25017675
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Makowska J. Use of nonsteroidal anti-inflammatory drugs in patients with aspirin hypersensitivity: safety of cyclo-oxygenase-2 inhibitors. Treat Respir Med. 2006;5(6):399–406.17154669
   PubMedGoogle Scholar
• Obase Y, Shimoda T, Tomari SY, et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. Chest. 2002;121(1):143–150.11796443
   PubMed Web of Science ®Google Scholar
• Dahlén SE, Malmström K, Nizankowska E, et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med. 2002;165(1):9–14.11779723
   PubMed Web of Science ®Google Scholar
• Dahlén B, Nizankowska E, Szczeklik A, et al. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med. 1998; 157 (4 Pt 1): 1187–1194.9563738
   PubMed Web of Science ®Google Scholar
• Ta V, White AA. Survey-defined patient experiences with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2015;3(5):711–718.25858054
   PubMed Web of Science ®Google Scholar
• Porcaro F, di Marco A, Cutrera R. Omalizumab in patient with aspirin exacerbated respiratory disease and chronic idiopathic urticaria. Pediatr Pulmonol. 2017;52(5):E26–E28.27685608
   PubMed Web of Science ®Google Scholar
• Gevaert P, van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;128(5):989–995.21958585
   PubMed Web of Science ®Google Scholar
• Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315(5):469–479.26836729
   PubMed Web of Science ®Google Scholar
• El Miedany Y, Youssef S, Ahmed I, et al. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2006;97(1):105–109.16892790
   PubMed Web of Science ®Google Scholar
• Koschel D, Weber CN, Höffken G. Tolerability to etoricoxib in patients with aspirin-exacerbated respiratory disease. J Investig Allergol Clin Immunol. 2013;23(4):275–280.
   PubMed Web of Science ®Google Scholar
• Prieto A, de Barrio M, Martín E, et al. Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance. J Allergy Clin Immunol. 2007;119(4):960–964.17292954
   PubMed Web of Science ®Google Scholar
• Asero R. Detection of aspirin reactivity in patients with pyrazolones-induced skin disorders. Allergy. 1998;53(2):214–215.9534925
   PubMed Web of Science ®Google Scholar
• Kim YJ, Lim KH, Kim MY, et al. Cross-reactivity to acetaminophen and celecoxib according to the type of nonsteroidal anti-inflammatory drug hypersensitivity. Allergy Asthma Immunol Res. 2014;6(2):156–162.24587953
   PubMed Web of Science ®Google Scholar
• Confino-Cohen R, Goldberg A. Safe full-dose one-step nabumetone challenge in patients with nonsteroidal anti-inflammatory drug hypersensitivity. Allergy Asthma Proc. 2003;24(4):281–284.12974196
   PubMed Web of Science ®Google Scholar
• Nabe T, Hashii H, Matsubara S, et al. A tiaramide derivative, 5-chloro-3-(4-hydroxypiperadinocarbonylmethyl)benzothiazoline-2-one (HPR-611), a potent inhibitor of anaphylactic chemical mediator release–a distinctive feature from disodium cromoglycate. J Pharmacobiodyn. 1992;15(12):673–679.1284281
   PubMedGoogle Scholar
• Inomata N, Osuna H, Yamaguchi J, et al. Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: comparison of meloxicam, etodolac and tiaramide. J Dermatol. 2007;34(3):172–177.17291297
   PubMed Web of Science ®Google Scholar
• Alenazy L, Alenazy L, Garcia-Neuer M, Castells M, et al. Drug hypersensitivity and desensitizations: mechanisms and new approaches. Int J Mol Sci. 2017;18(6):1316.
   Web of Science ®Google Scholar
• Bergmann KC, Zuberbier T, Church MK. Omalizumab in the treatment of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2015;3(3):459–460.25648572
   PubMed Web of Science ®Google Scholar
• Ta V, White AA. Survey-defined patient experiences with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2015;3(5):711–718.25858054
   PubMed Web of Science ®Google Scholar
• White AA, Stevenson DD. Aspirin-exacerbated respiratory disease. N Engl J Med. 2018;379(11):1060–1070.30207919
   PubMed Web of Science ®Google Scholar
• Grzelewska-Rzymowska I, Roznlecki J, Szmidt M. Aspirin desensitization in patients with aspirin-induced urticaria and angioedema. Allergol Immunopathol. 1988;16:305–308.
   PubMed Web of Science ®Google Scholar